Sponsor

Vaderis Therapeutics AG

Lichtstrasse 35, 4056

About the sponsor

Research activity is centred on vascular malformations, with attention to disorders affecting abnormal blood vessel formation and related vascular anomalies.

Congenital vascular disorders
Abnormal angiogenesis
Structural vessel malformations

The sponsor’s clinical portfolio reflects a focused interest in conditions within the vascular medicine and rare disease space.

About Specializations

Vaderis Therapeutics AG runs clinical trials in conditions such as Hereditary haemorrhagic telangiectasia, among others.

Hereditary haemorrhagic telangiectasia

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Hereditary haemorrhagic telangiectasia

Not yet recruiting

Investigational

A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

Investigational

Belgium

Participants:18–64 years · 65+ years
Sponsor:Vaderis Therapeutics AG

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →